PEB: Revenue up 22% as Pacific Edge advances new products and navigates Medicare coverage risks

About this update from Pacific Edge Limited

Pacific Edge reported 22% revenue growth and continued investment in clinical evidence, while addressing Medicare coverage uncertainty and preparing for new product launches. The company remains focused on profitable markets and operational efficiency.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Pacific Edge Limited